FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL

OMB Number: 3235-0104 Expires: January 31, 2005
Estimated average burden
hours per response. . . . . 0.5

1. Name and Address of Reporting Person^*
McManus, Michael (Last)                      (First)                      (Middle)
157 Technology Drive (Street) Irvine,    CA   92618 (City)                      (State)                      (Zip)
2. Date of Event
Requiring Statement
    Month/Day/Year
01/17/2003
3. I.R.S. Identification
    Number of Reporting
    Person, if an entity
    (voluntary) 4. Issuer Name andTicker or Trading Symbol
Spectrum Pharmaceuticals, Inc.
SPPI
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   Director      10% Owner X Officer (give title below)    
   Other (specify below)
Description     Controller 6. If Amendment,
    Date of Original
    (Month/Day/Year)

7. Individual or Joint/Group
    Filing (Check Applicable Line)
X   Form filed by One Reporting Person      Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned

1. Title of Security     (Instr. 4)	2. Amount of Securities Beneficially Owned     (Instr.4)	3. Ownership Form:     Direct (D)     or     Indirect (I)     (Instr. 5)	4. Nature of Indirect Beneficial Ownership     (Instr. 5)
Common Stock	5,000	D
Common Stock	24	I	Shares held in the Michael P. McManus SEP IRA

Table II - Derivative Securities Beneficially Owned

(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security     (Instr. 4)	2. Date Exercisable(DE) and     Expiration Date(ED)     (Month/Day/Year)   DE     /     ED	3. Title and Amount of     Underlying Securities     (Instr. 4) Title     /         Amount or Number of Shares	4. Conver-     sion or     Exercise     Price of     Deri-     vative     Security	5. Owner- ship Form of Deriv- ative Security: Direct (D) or Indirect (I) (Instr.5)	6. Nature of       Indirect       Beneficial       Ownership       (Instr.5)
Option to purchase common stock	(1) / 09/27/2012	Common Stock / 8,000	$1.00	D

Explanation of Responses:

(1) Such options become exercisable in 25% increments, commencing upon the date of grant and each three months thereafter, until fully vested.

By:	Date:
/s/ Michael P. McManus	03/19/2003
** Signature of Reporting Person	SEC 1473 (07-02)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.